AAD Guidelines of care for the management of atopic dermatitis in adults with phototherapy & systemic therapies

Published: 3 September 2023| Version 1 | DOI: 10.17632/s72kbfrfcv.1
AAD Guidelines


Background: For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered. Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD. These guidelines update the 2014 recommendations for management of AD with phototherapy and systemic therapies. Objective: To provide evidence-based recommendations on the use of phototherapy and systemic therapies for AD in adults. Methods: A multidisciplinary workgroup conducted a systematic review and applied the GRADE approach for assessing the certainty of evidence and formulating and grading recommendations.



American Academy of Dermatology


Dermatology, Evidence-Based Medicine, Atopic Dermatitis